Ibio Inc (IBIO) stock has risen 18.64% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With IBIO Stock Today?
Ibio Inc (IBIO) stock is up 11.11% while the S&P 500 has fallen -0.06% as of 11:51 AM on Tuesday, Jan 12. IBIO has risen $0.14 from the previous closing price of $1.26 on volume of 13,852,183 shares. Over the past year the S&P 500 has risen 15.49% while IBIO has risen 508.70%. IBIO lost -$0.83 per share in the over the last 12 months.
To screen for more stocks like Ibio Inc click here.
More About Ibio Inc
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc.
Click Here to get the full Stock Score Report on Ibio Inc (IBIO) Stock.
